Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewIcon is a Finnish private health technology company that develops, manufactures, and sells pharmacy automation systems for hospitals and retail pharmacies. Its core offerings include automated dispensing systems, automated dispensing cabinets, and robotic compounding systems used to improve medication safety, workflow efficiency, inventory control, and centralized pharmaceutical services. The company’s products include the Fixu G2 automated dispensing system, the eMED ICON smart dispensing cabinet, and the IV ICON Twins compounding system for sterile preparation workflows such as intravenous antibiotics. NewIcon is headquartered in Kuopio, Finland, and operates internationally through subsidiaries, joint ventures, and distributor partners. The company appears to be commercial-stage rather than therapeutics-focused, with revenue generated from installed automation systems, software, service, and support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewIcon.